Search by Drug Name or NDC

    NDC 10135-0741-05 Bisoprolol Fumarate and Hydrochlorothiazide 5; 6.25 mg/1; mg/1 Details

    Bisoprolol Fumarate and Hydrochlorothiazide 5; 6.25 mg/1; mg/1

    Bisoprolol Fumarate and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE.

    Product Information

    NDC 10135-0741
    Product ID 10135-741_f573476f-731c-6b4e-e053-2995a90aff47
    Associated GPIs 36992002130320
    GCN Sequence Number 021140
    GCN Sequence Number Description bisoprolol/hydrochlorothiazide TABLET 5-6.25MG ORAL
    HIC3 J7H
    HIC3 Description BETA-BLOCKERS AND THIAZIDE,THIAZIDE-LIKE DIURETICS
    GCN 45062
    HICL Sequence Number 008715
    HICL Sequence Number Description BISOPROLOL FUMARATE/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Bisoprolol Fumarate and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bisoprolol Fumarate and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5; 6.25
    Active Ingredient Units mg/1; mg/1
    Substance Name BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
    Labeler Name Marlex Pharmaceuticals, Inc.
    Pharmaceutical Class Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215562
    Listing Certified Through 2024-12-31

    Package

    NDC 10135-0741-05 (10135074105)

    NDC Package Code 10135-741-05
    Billing NDC 10135074105
    Package 500 TABLET in 1 BOTTLE (10135-741-05)
    Marketing Start Date 2022-05-01
    NDC Exclude Flag N
    Pricing Information N/A